Article Details

Aldeyra's Phase III clinical trial of Reproxalap meets primary endpoint

Retrieved on: 2024-08-09 17:06:53

Tags for this article:

Click the tags to see associated articles and topics

Aldeyra's Phase III clinical trial of Reproxalap meets primary endpoint. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Aldeyra Therapeutics Inc · View all. The Phase III randomised ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo